[Efficiency and value of modern diagnostic methods for cytomegalic inclusion disease].
D001787:Blood Group Incompatibility / Q000628:therapy; D001927:Brain Diseases / Q000150:complications; D002114:Calcinosis / Q000150:complications; D002675:Child, Preschool; D002825:Chorioretinitis / Q000150:complications; D003168:Complement Fixation Tests; D003520:Cyclophosphamide / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000150:complications / Q000175:diagnosis*; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D006130:Growth Disorders / Q000150:complications; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000175:diagnosis*; D007244:Infectious Mononucleosis / Q000209:etiology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000150:complications / Q000188:drug therapy; D008831:Microcephaly / Q000150:complications; D011241:Prednisone / Q000627:therapeutic use; D011247:Pregnancy; D011696:Purpura, Thrombocytopenic / Q000150:complications / Q000188:drug therapy; D012698:Serologic Tests; D014427:Twins
D003520:Cyclophosphamide; D011241:Prednisone
Leistungsfähigkeit und sinnvolle Anwendung der modernen Cytomegaliediagnostik.